Donepezil vs Pembrolizumab

## Donepezil vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Donepezil** and **Pembrolizumab**.

## Mechanism of Action

**Donepezil**: Reversible acetylcholinesterase inhibitor.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Donepezil — 70 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Donepezil — C24H29NO3; Pembrolizumab — N/A.

**Molecular Weight**: Donepezil — 379.4920 g/mol; Pembrolizumab — N/A.

**Type**: Donepezil — Small molecule; Pembrolizumab — Antibody.